Daniel R. Chevallard insider trades

Open-market stock purchases and sales by Daniel R. Chevallard, Chief Financial Officer at LENZ Therapeutics, Inc, from SEC Form 4 filings since May 10, 2017.

Track record: 0% of 4 scored buys are up 5% or more since purchase, averaging -57%.

Recent trades

DateStockTradeValue
Mar 27, 2026LENZ LENZ Therapeutics, IncBought$64.3K
Jan 2, 2026LENZ LENZ Therapeutics, IncBought (not open market)—
Jan 2, 2026LENZ LENZ Therapeutics, IncBought (not open market)—
Nov 7, 2025LENZ LENZ Therapeutics, IncBought$454
Nov 7, 2025LENZ LENZ Therapeutics, IncBought$49.6K

Companies traded

  • LENZ LENZ Therapeutics, Inc: 4 buys, last Mar 27, 2026
  • VIRX Viracta Therapeutics, Inc: 11 sales, last Mar 12, 2024
  • RGLS Regulus Therapeutics Inc: 1 buy, 3 sales, last Jul 1, 2019

Get free alerts when Daniel R. Chevallard files a new trade →